Similar Articles
1371 Effect and safety of sorafenib in patients with intermediate hepatocellular carcinoma who received transarterial chemoembolization: A retrospective comparative study
1372 Mouse models for investigating the underlying mechanisms of nonalcoholic steatohepatitis-derived hepatocellular carcinoma
1373 Multiomics biomarkers for the prediction of nonalcoholic fatty liver disease severity
1374 Analysis of aggressiveness factors in hepatocellular carcinoma patients undergoing transarterial chemoembolization
1375 Development and predictive validity of the cirrhosis-associated ascites symptom scale: A cohort study of 103 patients
1376 Correlations between microbial communities in stool and clinical indicators in patients with metabolic syndrome
1377 Correlation between metabolic syndrome and sleep apnea
1378 Nonalcoholic fatty liver disease and liver transplantation - Where do we stand?
1379 Mild drinking habit is a risk factor for hepatocarcinogenesis in non-alcoholic fatty liver disease with advanced fibrosis
1380 Hepatocellular carcinoma or interferon-based therapy history attenuates sofosbuvir/ribavirin for Japanese genotype 2 hepatitis C virus
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA